Amid growing financial concerns and US vaccine hesitancy, the German company will close its mRNA site in Southeast Asia.

President Trump enacts tariffs on imported drugs to strengthen US manufacturing, sparking industry concerns over costs, ...

Leaders from around the industry discuss areas that stakeholders can explore to lower costs and improve accessibility.

Drug developers weigh building internal radiopharmaceutical capabilities versus outsourcing amid timeline and funding ...

Explore the latest news and expert commentary by Stephen Cheng, brought to you by the Contributor of BioProcess International ...

Explore the latest news and expert commentary by Steven Gravallese, brought to you by the Contributor of BioProcess ...

Explore how life-science companies adapt office spaces to balance hybrid work flexibility with the need for innovation, ...

Lonza partners with ImmuneOncia to manufacture Danburstotug, a promising mAb therapy for rare NK/T-cell lymphoma, advancing ...

Learn how relative quantification provides coverage of the total host cell protein population, enabling assessment of process ...

Explore how biopharmaceutical companies are navigating capital constraints, rising R&D costs, and regulatory demands amid ...

Learn how integrated development strategies, advanced technology platforms, and a robust CMC framework enable faster ...

Respondents to a survey note an urgent need for role-specific training to bridge knowledge gaps in advanced-therapy ...